Frencken Group Limited reported net profit attributable to shareholders of S$19.27 million for the six months ended Jun 30 2026, a 3.4% year-on-year (YoY) decline that nevertheless outpaced the marginal 0.8% fall in revenue to S$427.80 million, supported by an improved gross profit margin.

Earnings per share slipped to 4.50 Singapore cents from 4.67 cents a year earlier. The board did not declare an interim dividend, in line with its practice of proposing distributions only at the full-year.

Group gross profit rose 5.8 % to S$64.38 million, lifting the margin to 15.0% from 14.1% in the prior-year period. Finance costs fell 35.0% to S$1.94 million on lower borrowings.

By segment, the Mechatronics Division generated S$383.40 million in revenue (-1.5 % YoY) and S$21.53 million in pre-tax earnings. Within Mechatronics, semiconductor sales accounted for 49.9 % of group revenue, edging 1.1 % lower to S$213.27 million for the half-year, while medical revenue increased 10.1 % to S$70.51 million. Analytical life sciences revenue contracted 13.7 % to S$75.29 million, and industrial automation rose 9.8 % to S$18.43 million.

The Advanced Plastics Solutions (APS) Division lifted revenue 3.6 % to S$42.04 million, driven by a 10.0 % increase in automotive sales to S$32.15 million that offset softer consumer and industrial electronics demand. APS contributed S$1.37 million to pre-tax earnings. Investment Holding & Management Services and Other operations added S$2.71 million and S$0.87 million respectively.

Administrative and general expenses climbed 9.9 % to S$32.62 million, reflecting higher staff-related and transformation costs, while a net foreign-exchange loss cut other income, reducing overall gains from ancillary items by 42.2 % to S$1.45 million. Income tax expense increased 12.4 % to S$5.43 million, resulting in a group profit before tax of S$25.03 million, up 1.1 % YoY.

Operating cash flow swung to an outflow of S$4.82 million as inventories and receivables built up to meet customer orders. After S$13.68 million of net investing cash outflows—mainly for S$8.84 million of capital expenditure—and S$38.73 million of financing outflows, cash and cash equivalents stood at S$105.27 million on Jun 30, with net cash of about S$68.8 million and a debt-to-equity ratio of 11.1 %.

Looking ahead, management anticipates higher revenue in the second half of 2026 versus both 1H26 and 2H25, supported by strong order visibility in the semiconductor segment, a steady medical pipeline and continued growth in automotive plastics. The group is targeting S$1 billion in annual revenue by 2028 through a combination of organic expansion—including a new Singapore facility slated for 2H27—and selective mergers and acquisitions, while progressing with an organisation-wide ERP upgrade expected to complete in 2027.